Efruxifermin in non-alcoholic steatohepatitis

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1058-1059
Number of pages	2
Journal	The Lancet Gastroenterology & Hepatology
Volume	8
Issue number	12
Early online date	3 Oct 2023
DOIs	https://doi.org/10.1016/S2468-1253(23)00285-6
Publication status	Published - Dec 2023

Keywords

@article{b2f6e516cf5c4ced809d853c831accd4,

title = "Efruxifermin in non-alcoholic steatohepatitis",

keywords = "Humans, Non-alcoholic Fatty Liver Disease/complications",

author = "Sara Mahgoub and Newsome, {Philip N}",

year = "2023",

month = dec,

doi = "10.1016/S2468-1253(23)00285-6",

language = "English",

volume = "8",

pages = "1058--1059",

journal = "The Lancet Gastroenterology & Hepatology",

issn = "2468-1253",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - Efruxifermin in non-alcoholic steatohepatitis

AU - Mahgoub, Sara

AU - Newsome, Philip N

PY - 2023/12

Y1 - 2023/12

KW - Humans

KW - Non-alcoholic Fatty Liver Disease/complications

U2 - 10.1016/S2468-1253(23)00285-6

DO - 10.1016/S2468-1253(23)00285-6

M3 - Comment/debate

C2 - 37802089

SN - 2468-1253

VL - 8

SP - 1058

EP - 1059

JO - The Lancet Gastroenterology & Hepatology

JF - The Lancet Gastroenterology & Hepatology

IS - 12

ER -